FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100071832> ?p ?o ?g. }

• W2100071832 endingPage "S15" @default.
• W2100071832 startingPage "S9" @default.
• W2100071832 abstract "The study reported here was undertaken to assess medium short-term efficacy of focal cryoablation as primary therapy for localized prostate cancer and to determine the rate of morbidity in patients who undergo this treatment. Patients were treated with focal cryoablation with argon cryoprobes under ultrasonographic visualization with temperature monitoring. Men who were potent at the time of intervention were encouraged to use a vacuum erectile dysfunction device on a regular basis after treatment. Incontinence was defined as any urine leakage regardless of the number of pads worn (if any). Potency was defined as the ability to achieve an erection sufficient to complete intercourse with or without oral pharmaceuticals. Biochemical failure was defined as 3 successive rises in serum prostate-specific antigen (PSA) concentration. A total of 60 consecutive patients were treated. Mean patient age was 69.0 years; mean PSA was 7.2 ng/mL, median Gleason score was 6, and median stage was T1c. Before treatment was initiated, all patients were continent and 72.7% were potent. Mean follow-up for the entire population was 15.2+/-7.4 months. Of those patients who were continent before receiving treatment, 3.6% were incontinent at 6 months, but none used any absorbent pads. At last follow-up, 80.4% of patients were biochemically disease free; mean time to failure was 3.5 months among those for whom treatment failed. The positive biopsy rate after first treatment was 23.3%, and mean time to failure was 12.0 months. Of those who underwent a second focal cryoablation procedure after positive biopsy, 66% were subsequently cancer free. All patients who were potent after the first cryoablation procedure regained their potency after the second cryoablation procedure. Focal cryoablation combined with penile rehabilitation as primary treatment for localized prostate cancer is a minimally morbid procedure with acceptable morbidity and the potential for retreatment of a patient if cancer is subsequently detected. Further study is warranted." @default.
• W2100071832 created "2016-06-24" @default.
• W2100071832 creator A5005264312 @default.
• W2100071832 creator A5016496469 @default.
• W2100071832 creator A5088854105 @default.
• W2100071832 date "2007-12-01" @default.
• W2100071832 modified "2023-09-27" @default.
• W2100071832 title "Focal Cryosurgery Followed by Penile Rehabilitation as Primary Treatment for Localized Prostate Cancer: Initial Results" @default.
• W2100071832 cites W1846391742 @default.
• W2100071832 cites W1966372077 @default.
• W2100071832 cites W1989739561 @default.
• W2100071832 cites W1989920747 @default.
• W2100071832 cites W2025615793 @default.
• W2100071832 cites W2041940347 @default.
• W2100071832 cites W2065053123 @default.
• W2100071832 cites W2070638378 @default.
• W2100071832 cites W2080046326 @default.
• W2100071832 cites W2085864366 @default.
• W2100071832 cites W2096260602 @default.
• W2100071832 cites W2147599714 @default.
• W2100071832 cites W2153314120 @default.
• W2100071832 cites W2153674426 @default.
• W2100071832 cites W2154861747 @default.
• W2100071832 cites W2160537008 @default.
• W2100071832 doi "https://doi.org/10.1016/j.urology.2007.07.036" @default.
• W2100071832 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18194712" @default.
• W2100071832 hasPublicationYear "2007" @default.
• W2100071832 type Work @default.
• W2100071832 sameAs 2100071832 @default.
• W2100071832 citedByCount "147" @default.
• W2100071832 countsByYear W21000718322012 @default.
• W2100071832 countsByYear W21000718322013 @default.
• W2100071832 countsByYear W21000718322014 @default.
• W2100071832 countsByYear W21000718322015 @default.
• W2100071832 countsByYear W21000718322016 @default.
• W2100071832 countsByYear W21000718322017 @default.
• W2100071832 countsByYear W21000718322018 @default.
• W2100071832 countsByYear W21000718322019 @default.
• W2100071832 countsByYear W21000718322020 @default.
• W2100071832 countsByYear W21000718322021 @default.
• W2100071832 countsByYear W21000718322022 @default.
• W2100071832 countsByYear W21000718322023 @default.
• W2100071832 crossrefType "journal-article" @default.
• W2100071832 hasAuthorship W2100071832A5005264312 @default.
• W2100071832 hasAuthorship W2100071832A5016496469 @default.
• W2100071832 hasAuthorship W2100071832A5088854105 @default.
• W2100071832 hasConcept C121608353 @default.
• W2100071832 hasConcept C126322002 @default.
• W2100071832 hasConcept C126894567 @default.
• W2100071832 hasConcept C141071460 @default.
• W2100071832 hasConcept C146357865 @default.
• W2100071832 hasConcept C151730666 @default.
• W2100071832 hasConcept C2775934546 @default.
• W2100071832 hasConcept C2776235491 @default.
• W2100071832 hasConcept C2777628079 @default.
• W2100071832 hasConcept C2778902805 @default.
• W2100071832 hasConcept C2779929075 @default.
• W2100071832 hasConcept C2780106285 @default.
• W2100071832 hasConcept C2780149145 @default.
• W2100071832 hasConcept C2780192828 @default.
• W2100071832 hasConcept C2908647359 @default.
• W2100071832 hasConcept C54847362 @default.
• W2100071832 hasConcept C71924100 @default.
• W2100071832 hasConcept C86803240 @default.
• W2100071832 hasConcept C99454951 @default.
• W2100071832 hasConceptScore W2100071832C121608353 @default.
• W2100071832 hasConceptScore W2100071832C126322002 @default.
• W2100071832 hasConceptScore W2100071832C126894567 @default.
• W2100071832 hasConceptScore W2100071832C141071460 @default.
• W2100071832 hasConceptScore W2100071832C146357865 @default.
• W2100071832 hasConceptScore W2100071832C151730666 @default.
• W2100071832 hasConceptScore W2100071832C2775934546 @default.
• W2100071832 hasConceptScore W2100071832C2776235491 @default.
• W2100071832 hasConceptScore W2100071832C2777628079 @default.
• W2100071832 hasConceptScore W2100071832C2778902805 @default.
• W2100071832 hasConceptScore W2100071832C2779929075 @default.
• W2100071832 hasConceptScore W2100071832C2780106285 @default.
• W2100071832 hasConceptScore W2100071832C2780149145 @default.
• W2100071832 hasConceptScore W2100071832C2780192828 @default.
• W2100071832 hasConceptScore W2100071832C2908647359 @default.
• W2100071832 hasConceptScore W2100071832C54847362 @default.
• W2100071832 hasConceptScore W2100071832C71924100 @default.
• W2100071832 hasConceptScore W2100071832C86803240 @default.
• W2100071832 hasConceptScore W2100071832C99454951 @default.
• W2100071832 hasIssue "6" @default.
• W2100071832 hasLocation W21000718321 @default.
• W2100071832 hasLocation W21000718322 @default.
• W2100071832 hasOpenAccess W2100071832 @default.
• W2100071832 hasPrimaryLocation W21000718321 @default.
• W2100071832 hasRelatedWork W1497406605 @default.
• W2100071832 hasRelatedWork W1998700940 @default.
• W2100071832 hasRelatedWork W2009573387 @default.
• W2100071832 hasRelatedWork W2022571942 @default.
• W2100071832 hasRelatedWork W2035639984 @default.
• W2100071832 hasRelatedWork W2077097335 @default.
• W2100071832 hasRelatedWork W2185711004 @default.
• W2100071832 hasRelatedWork W2313231227 @default.
• W2100071832 hasRelatedWork W2388887117 @default.

• next